Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Colorcon
Baxter
Mallinckrodt
Medtronic

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

CARBASTAT Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Carbastat patents expire, and when can generic versions of Carbastat launch?

Carbastat is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in CARBASTAT is carbachol. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the carbachol profile page.

Summary for CARBASTAT
Drug patent expirations by year for CARBASTAT
Synonyms for CARBASTAT
(2-Carbamoyloxy-ethyl)-trimethyl-ammonium
(carbachol)(2-Carbamoyloxy-ethyl)-trimethyl-ammonium
1uv6
2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium
2-(carbamoyloxy)-N,N,N-trimethylethanaminium
2-[(AMINOCARBONYL)OXY]-N,N,N-TRIMETHYLETHANAMINIUM
2-carbamoyloxyethyl-trimethylazanium
2-carbamoyloxyethyl(trimethyl)azanium
462-58-8
54Z8M50D6Q
AB00053795
AB00053795_09
AB00053795_10
AB00053795-08
AC1L1DXK
AC1Q65QH
AKOS025247582
BC224240
BDBM50004656
BPBio1_001055
BSPBio_000959
BSPBio_001927
Carbachol USP27
Carbamoylcholine
CARBAMYL-CHOLINE
Carbamylcholine
carbamylcholinechloride
Carbastat intraocular
Carboptic
CAS-51-83-2
CCE
CCG-204338
CHEMBL14
CHEMBL965
Choline, carbonate (ester)
CTK1D5875
DivK1c_000725
DTXSID0048397
Ethanaminium, 2-((aminocarbonyl)oxy)-N,N,N-trimethyl-
GTPL298
HMS2089I06
IDI1_000725
KBio1_000725
KBio2_000514
KBio2_003082
KBio2_005650
KBio3_001147
KBioGR_000722
KBioSS_000514
Lopac-C-4382
Lopac0_000243
LS-185872
LS-187126
MCULE-5642570831
MolPort-005-942-293
NCGC00015237-01
NCGC00015237-02
NCGC00015237-03
NCGC00015237-04
NCGC00015237-05
NCGC00162103-01
NCGC00163219-01
NINDS_000725
Prestwick0_000880
Prestwick1_000880
Prestwick2_000880
Prestwick3_000880
SBI-0050231.P004
SCHEMBL2792
SPBio_000128
SPBio_002880
Spectrum_000094
Spectrum2_000114
Spectrum3_000324
Spectrum4_000261
Spectrum5_000934
STL371210
UNII-54Z8M50D6Q
ZINC3079342

US Patents and Regulatory Information for CARBASTAT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis CARBASTAT carbachol SOLUTION;INTRAOCULAR 073677-001 Apr 28, 1995 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Baxter
Mallinckrodt
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.